Arcellx (ACLX)

• Market cap: $6.58B
• 1 day: 77.43%
• 5 days: 65.5%
• 1 month: 68.02%
• 3 months: 51.75%
• 6 months: 66.08%
• Year to date: 79.59%
• 1 year: 80.53%
• 5 years: 577.08%
• 10 years: 577.08%
• Sector: Healthcare
• Industry: Biotechnology

About: Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.

Employees: 163